SurModics Shares Outstanding vs. Shares Owned By Institutions

SRDX Stock  USD 39.45  0.09  0.23%   
Based on SurModics' profitability indicators, SurModics may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess SurModics' ability to earn profits and add value for shareholders. Sales General And Administrative To Revenue is likely to rise to 0.44 in 2024, whereas Price To Sales Ratio is likely to drop 4.14 in 2024. At this time, SurModics' Income Tax Expense is fairly stable compared to the past year. Non Operating Income Net Other is likely to rise to about 279.3 K in 2024, despite the fact that Accumulated Other Comprehensive Income is likely to grow to (4.1 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.780.7381
Notably Up
Slightly volatile
For SurModics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of SurModics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well SurModics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between SurModics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of SurModics over time as well as its relative position and ranking within its peers.
  

SurModics' Revenue Breakdown by Earning Segment

Check out World Market Map.
For more information on how to buy SurModics Stock please use our How to Invest in SurModics guide.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SurModics. If investors know SurModics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SurModics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
4.358
Earnings Share
(0.82)
Revenue Per Share
8.908
Quarterly Revenue Growth
0.188
Return On Assets
(0.01)
The market value of SurModics is measured differently than its book value, which is the value of SurModics that is recorded on the company's balance sheet. Investors also form their own opinion of SurModics' value that differs from its market value or its book value, called intrinsic value, which is SurModics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SurModics' market value can be influenced by many factors that don't directly affect SurModics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SurModics' value and its price as these two are different measures arrived at by different means. Investors typically determine if SurModics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SurModics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

SurModics Shares Owned By Institutions vs. Shares Outstanding Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining SurModics's current stock value. Our valuation model uses many indicators to compare SurModics value to that of its competitors to determine the firm's financial worth.
SurModics is rated below average in shares outstanding category among its peers. It is rated fourth in shares owned by institutions category among its peers . The ratio of Shares Outstanding to Shares Owned By Institutions for SurModics is about  172,457 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SurModics' earnings, one of the primary drivers of an investment's value.

SurModics Shares Owned By Institutions vs. Shares Outstanding

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

SurModics

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
14.33 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

SurModics

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
83.07 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

SurModics Shares Owned By Institutions Comparison

SurModics is currently under evaluation in shares owned by institutions category among its peers.

SurModics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in SurModics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, SurModics will eventually generate negative long term returns. The profitability progress is the general direction of SurModics' change in net profit over the period of time. It can combine multiple indicators of SurModics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-4.3 M-4.1 M
Operating Income-5.6 M-5.4 M
Income Before Tax-7.5 M-7.1 M
Total Other Income Expense Net-1.9 M-2 M
Net Loss-11.5 M-11 M
Income Tax ExpenseMM
Net Loss-24.5 M-23.3 M
Net Loss-11.5 M-11 M
Non Operating Income Net Other181.8 K279.3 K
Interest Income1.2 M1.3 M
Net Interest Income-3.5 M-3.4 M
Change To Netincome15.2 M15.9 M
Net Loss(0.82)(0.77)
Income Quality(0.02)(0.02)
Net Income Per E B T 1.54  1.61 

SurModics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on SurModics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of SurModics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the SurModics' important profitability drivers and their relationship over time.

Use SurModics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if SurModics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SurModics will appreciate offsetting losses from the drop in the long position's value.

SurModics Pair Trading

SurModics Pair Trading Analysis

The ability to find closely correlated positions to SurModics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SurModics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SurModics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SurModics to buy it.
The correlation of SurModics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SurModics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SurModics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for SurModics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your SurModics position

In addition to having SurModics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Latest Gainers Thematic Idea Now

Latest Gainers
Latest Gainers Theme
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Gainers theme has 232 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Gainers Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for SurModics Stock Analysis

When running SurModics' price analysis, check to measure SurModics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SurModics is operating at the current time. Most of SurModics' value examination focuses on studying past and present price action to predict the probability of SurModics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SurModics' price. Additionally, you may evaluate how the addition of SurModics to your portfolios can decrease your overall portfolio volatility.